James Neal, Director at Processa Pharmaceuticals, holds 1.02K shares in Processa Pharmaceuticals (Ticker: PCSA), holds 36.27K shares in Akari Therapeutics (Ticker: AKTX), holds 0.00 shares in Peak Bio (Ticker: PKBO).
What is the percentage of profitable transactions made by James Neal?
The percentage of profitable transactions made by James Neal is 87%.
What is the average return per transaction made by James Neal?
The average return per transaction made by James Neal is 47.50%.
What stocks does James Neal hold?
James Neal holds: PCSA, PKBO, AKTX, XOMA, PALI stocks.
What was James Neal’s latest transaction?
James Neal latest transaction was an Uninformative Buy of $377.58.
What was James Neal's most profitable transaction?
James Neal’s most profitable transaction was an Informative Buy of XOMA stock on December 21, 2018. The return on the trade was 116.00%.
What is James Neal's role in Processa Pharmaceuticals?
James Neal's role in Processa Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.